India Pharma Outlook Team | Friday, 10 February 2023
Meenakshi Nevatia has been appointed by Pfizer Limited as the company's managing director and additional director for a term of five years beginning on April 3, 2023. S.Sridhar, who announced his early retirement in August 2022, is succeeded by her. Meenakshi is an experienced business executive with close to 30 years of experience working for prestigious firms like Mckinsey and Company, Novartis Pharmaceuticals, and most recently, Stryker Corporation.
Meenakshi has held a number of General Management positions in a variety of markets, including Thailand, Spain (Iberia), and India. She has worked in over 8 countries, both established and emerging. The Nomination & Remuneration Committee's recommendation was taken into consideration by the Board of Directors of Pfizer Limited at their meeting on February 9th, 2023, and Meenakshi was appointed as the company's managing director effective April 3rd. At the end of business on March 31, 2023, S. Sridhar, the present India Country President, will resign as Managing Director and Member of the Board.